GMAB

Genmab A/S ADS
D

GMAB

Arincen61/100B

Who owns Genmab A?

Institutions own 16.7% of Genmab A/S ADS's shares, through 307 funds, banks and other managers that report their holdings to the SEC; individual investors and others hold the rest. The largest on 30 June 2026 were Paradigm Biocapital Advisors LP (2.1%), Orbis Allan Gray Ltd (1.9%), Alliancebernstein L.P. (1.4%).

Institutions own
16.7%
Institutional holders
307
The 10 largest hold
10.8%
Free float
95.5%
Holdings as of
30 Jun 2026

Who owns the shares

10 largest holders 10.8% Other institutions 5.9% Individuals and others 83.3%

Shares free to trade

Free float 589.06M shares ·95.5% Closely held 27.54M shares ·4.5%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

The largest shareholders

#HolderSharesOf the companyValueChange last quarter (shares)
1Paradigm Biocapital Advisors LP13,133,1312.14%360.77M USD+5,165,295
2Orbis Allan Gray Ltd11,368,1611.85%312.28M USD-1,557,417
3Alliancebernstein L.P.8,644,8771.41%231.94M USD-912,272
4Deerfield Management Company, L.P.6,865,0001.12%188.58M USD+4,403,000
5Deep Track Capital, LP5,650,0000.92%155.21M USD+1,986,750
6Arrowstreet Capital, Limited Partnership4,975,3240.81%136.67M USD0
7BlackRock, Inc.4,671,2520.76%128.32M USD+134,687
8Sofinnova Investments, Inc.4,045,2150.66%111.12M USD+3,292,954
9Renaissance Technologies LLC3,517,8500.57%96.64M USD-896,700
10Two Sigma Investments, LP3,506,8430.57%96.33M USD+1,167,411

Famous investors who own Genmab A

InvestorOf their portfolioSharesValueLast quarter
Renaissance TechnologiesQ3 20260.11%2,272,45081.07M USD-35.4%Reduced
Ken GriffinCitadel · Q2 2026<0.01%2,475,99168.02M USD+12,861.9%Added

From each fund's newest 13F filing with the SEC; a fund's quarter can be newer or older than another's.All famous investors' portfolios

Congress trades in Genmab A/S ADS

Over the last 12 months, 1 members bought it (1 trades) and 0 sold it (0 trades).

MemberTradeOwnerAmountTradedDisclosedSince the tradeReport
RAlan ArmstrongSenator for OklahomaBoughtSelf$1,001 - $15,00030 Mar 2026
21 Jul 2026113 days later
+98.8%
DJosh GottheimerRepresentative for New Jersey's 5th districtBoughtJoint$1,001 - $15,00016 Jan 2025
11 Feb 202526 days later
+142.1%
DJosh GottheimerRepresentative for New Jersey's 5th districtSold allJoint$1,001 - $15,00016 Dec 2024
14 Jan 202529 days later
+156.5%

Members of Congress must report a trade over $1,000 within 45 days, its amount as a range. A trade by a spouse or child is theirs to report too. The move since the trade is from the close on the day traded to the price now.All Congress stock trades

All institutions last quarter

Bought or added
202 · 50 new
Sold or cut
136 · 33 sold out
Net shares bought
+20.58M · 565.43M USD
Institutional ownership
13.3% → 16.7%

Biggest buyers last quarter

  • Paradigm Biocapital Advisors LP+5,165,295
  • Deerfield Management Company, L.P.+4,403,000
  • Sofinnova Investments, Inc.+3,292,954
  • Deep Track Capital, LPNew position
  • Citadel Advisors LLC+2,475,991

Biggest sellers last quarter

  • Orbis Allan Gray Ltd-1,557,417
  • Alliancebernstein L.P.-912,272
  • Renaissance Technologies LLC-896,700
  • Morgan Stanley-554,540
  • FMR LLC-247,032

From the holders' 13F filings with the SEC for the quarter to 30 Jun 2026, filed up to 45 days after it; the buyers and sellers are among the 100 largest holders.

Common questions about Genmab A's shareholders

Source: Financial Modeling Prep